Aug. 20 at 3:14 PM
$AVAI Avant Technologies (OTCQB:
$AVAI) News Update
⚡️ Avant Technologies (OTCQB:
$AVAI) and Ainnova Tech Announce Enhanced Patient Recruitment Strategy Ahead of FDA Clinical Trial ⚡️
The planned clinical study, which will be performed in 8-10 clinical sites around the U.S., will prioritize the recruitment of approximately 1,000 multiethnic patients, with a focus on individuals living with diabetes.
💥 We are getting closer to initiating a clinical study that will significantly contribute to obtaining FDA 510(k) approval.